Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Product sales, net $ 8,270 $ 14,911
Cost of goods sold 4,262 4,352
Gross Profit 4,008 10,559
Operating expenses:    
Research and development 1,509 1,342
Selling, general and administrative 7,819 18,595
Total operating expenses 9,328 19,937
Operating Loss (5,320) (9,378)
Other Expenses [Abstract]    
Interest (income) expense, net (10) 6
Loss before income taxes (5,310) (9,384)
Income tax benefit (158) 0
Net Loss $ (5,152) $ (9,384)
Weighted average common shares outstanding, basic and diluted 99,678 95,168
Net loss per common share, basic and diluted (in USD per share) $ (0.05) $ (0.10)